Thomas E. Mürdter
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
Papers in
- Pharmacology 30
- Pharmacogenetics and Drug Metabolism 29
- Inflammatory mediators and NSAID effects 10
- Genetics 26
- Estrogen and related hormone effects 25
- Co-authors
- Matthias Georg Schwab (47 shared papers)Michel F Eichelbaum (15 shared papers)Georg Heinkele (16 shared papers)Ulrich M. Zanger (12 shared papers)Péter Fritz (20 shared papers)Hiltrud B. Brauch (14 shared papers)Ute Hofmann (17 shared papers)Ulrich E. Klotz (12 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (7 papers)Analytical and Bioanalytical Chemistry (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Cancers (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Thomas E. Mürdter
110 papers receiving 3.5k citations
Thomas E. Mürdter's Hit Papers
Peers
Comparison fields: 5 of 125
- Pharmacology 908
- Oncology 869
- Pharmacology 355
- Pharmaceutical Science 111
- Cancer Research 226
Countries citing papers authored by Thomas E. Mürdter
This map shows the geographic impact of Thomas E. Mürdter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Mürdter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Mürdter more than expected).
Fields of papers citing papers by Thomas E. Mürdter
This network shows the impact of papers produced by Thomas E. Mürdter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Mürdter. The network helps show where Thomas E. Mürdter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Mürdter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy Hit paper breakdown → | 2013 | 310 |
| 2 | 2004 | 216 | |
| 3 | 2009 | 196 | |
| 4 | 2014 | 173 | |
| 5 | 2009 | 126 | |
| 6 | 2003 | 125 | |
| 7 | 2002 | 116 | |
| 8 | 2007 | 97 | |
| 9 | 2006 | 94 | |
| 10 | 2000 | 78 | |
| 11 | 2003 | 73 | |
| 12 | 2002 | 73 | |
| 13 | 2010 | 69 | |
| 14 | 2016 | 68 | |
| 15 | Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. | 1997 | 65 |
| 16 | 2008 | 62 | |
| 17 | 2008 | 58 | |
| 18 | 2017 | 51 | |
| 19 | 2002 | 49 | |
| 20 | 2016 | 46 |
About Thomas E. Mürdter
Thomas E. Mürdter is a scholar working on Pharmacology, Genetics, Oncology, Cancer Research and Pharmacology, having authored 114 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (29 papers), Estrogen and related hormone effects (25 papers), Inflammatory mediators and NSAID effects (10 papers), Cancer, Hypoxia, and Metabolism (10 papers), RNA Interference and Gene Delivery (9 papers), Drug Transport and Resistance Mechanisms (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Toxin Mechanisms and Immunotoxins (6 papers). The work is most often cited by research in Pharmacology (908 citations), Oncology (869 citations), Pharmacology (355 citations), Pharmaceutical Science (111 citations) and Cancer Research (226 citations). Thomas E. Mürdter has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Matthias Georg Schwab, Michel F Eichelbaum, Georg Heinkele, Ulrich M. Zanger, Péter Fritz, Hiltrud B. Brauch, Ute Hofmann, Ulrich E. Klotz, Reinhold Kerb and Godehard Friedel. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Analytical and Bioanalytical Chemistry, European Journal of Pharmaceutics and Biopharmaceutics, Cancers and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.